Ipca Laboratories Ltd
NSE: IPCALAB BSE: 524494
₹1533.90
(2.86%)
Fri, 13 Mar 2026, 04:45 am
Market Cap378.03B
PE Ratio42.77
Dividend0.27
Health Technology
Pharmaceuticals: Major
24.5KIpca Laboratories Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.56B | 9.30B | 10.84B | 12.80B | 15.60B | 18.83B | 23.30B | 27.74B | 32.29B | 31.17B | 28.37B | 31.06B | 32.18B | 37.01B | 45.72B | 53.74B | 57.63B | 61.97B | 76.13B | 88.49B |
| Gross profit | 1.15B | 1.69B | 1.77B | 2.21B | 5.33B | 6.66B | 8.28B | 9.65B | 12.64B | 9.58B | 7.54B | 8.80B | 9.12B | 11.07B | 13.63B | 19.59B | 17.66B | 16.92B | 21.90B | 28.48B |
| Operating expenses (excl. COGS) | -167.01M | -53.00M | -231.30M | 73.80M | -2.81B | -3.59B | -4.06B | -4.62B | -6.04B | -6.27B | -5.95B | -6.57B | -6.54B | -6.02B | -6.56B | -6.50B | -7.16B | -9.60B | -13.91B | -15.22B |
| Selling/general/admin expenses, total | — | — | — | — | -2.73B | -3.52B | -3.97B | -4.48B | -5.82B | -6.04B | -5.81B | -6.42B | -6.42B | -5.95B | -6.44B | -6.37B | -7.31B | -9.75B | -12.76B | -15.27B |
| Research & development | -151.20M | -104.00M | -142.70M | -240.30M | -288.00M | -299.60M | -252.50M | -355.40M | -1.13B | -1.08B | -1.20B | -1.20B | -996.50M | -828.50M | -964.50M | -1.21B | -1.18B | -1.31B | -1.71B | -2.51B |
| Selling/general/admin expenses, other | — | — | — | — | -2.44B | -3.22B | -3.71B | -4.12B | -4.69B | -4.96B | -4.61B | -5.22B | -5.43B | -5.12B | -5.48B | -5.16B | -6.13B | -8.44B | -11.06B | -12.76B |
| Other operating expenses, total | -167.01M | -53.00M | -231.30M | 73.80M | -79.90M | -67.90M | -91.10M | -140.70M | -217.50M | -236.40M | -136.40M | -148.00M | -115.00M | -68.70M | -113.40M | -133.80M | 151.50M | 148.20M | -1.15B | 48.70M |
| Operating income | 836.03M | 1.53B | 1.40B | 2.05B | 2.52B | 3.08B | 4.22B | 5.03B | 6.60B | 3.31B | 1.59B | 2.23B | 2.59B | 5.06B | 7.07B | 13.09B | 10.50B | 7.31B | 7.98B | 13.26B |
| Non-operating income, total | -116.03M | -17.60M | 301.50M | -924.50M | 139.60M | 331.70M | -581.70M | -486.00M | -293.00M | 297.80M | -428.20M | 385.60M | 318.20M | 408.10M | 398.10M | 801.30M | 853.80M | 139.20M | 446.10M | -1.95B |
| Interest expense, net of interest capitalized | -132.69M | -246.90M | -186.10M | -312.20M | -273.90M | -230.30M | -442.90M | -361.60M | -297.30M | -318.70M | -345.50M | -259.10M | -263.40M | -205.40M | -197.70M | -112.50M | -102.00M | -458.10M | -1.30B | -878.40M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 24.92M | 234.20M | 493.30M | -609.90M | 449.90M | 580.60M | -129.90M | -112.60M | 14.10M | 598.80M | 22.00M | 675.20M | 629.40M | 682.00M | 864.70M | 1.08B | 894.90M | 575.40M | 2.04B | 1.39B |
| Non-operating interest income | 16.17M | 22.20M | 35.80M | 59.50M | 65.50M | 59.00M | 71.30M | 85.40M | 133.90M | 188.50M | 127.10M | 127.20M | 151.30M | 274.50M | 323.00M | 369.50M | 341.70M | 793.50M | 629.30M | 351.20M |
| Miscellaneous non-operating expense | 8.75M | 212.00M | 457.50M | -669.40M | 384.40M | 521.60M | -201.20M | -198.00M | -119.80M | 410.30M | -105.10M | 630.60M | 520.40M | 425.60M | 541.70M | 707.30M | 553.20M | -218.10M | 1.41B | 1.04B |
| Unusual income/expense | -8.26M | -4.90M | -5.70M | -2.40M | -36.40M | -18.60M | -8.90M | -11.80M | -9.80M | 17.70M | -104.70M | -30.50M | -47.80M | -68.50M | -268.90M | -163.00M | 60.90M | 21.90M | -295.00M | -2.46B |
| Pretax income | 720.00M | 1.52B | 1.70B | 1.12B | 2.66B | 3.41B | 3.64B | 4.54B | 6.31B | 3.61B | 1.17B | 2.62B | 2.91B | 5.46B | 7.47B | 13.89B | 11.36B | 7.45B | 8.43B | 11.31B |
| Taxes | -119.77M | -265.80M | -304.90M | -172.50M | -627.20M | -783.80M | -881.10M | -1.30B | -1.52B | -1.02B | -204.40M | -675.20M | -511.10M | -1.04B | -1.35B | -2.40B | -2.25B | -2.53B | -3.13B | -3.44B |
| Non-controlling/minority interest | 0 | 0 | 0 | 3.80M | 2.00M | 800.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.10M | 27.60M | -11.30M | -57.10M | -76.70M | 244.30M | -475.60M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 615.05M | 1.25B | 1.36B | 1.01B | 2.05B | 2.63B | 2.77B | 3.24B | 4.79B | 2.54B | 931.40M | 1.95B | 2.39B | 4.45B | 6.06B | 11.40B | 8.84B | 4.71B | 5.47B | 7.38B |
| Net income | 615.05M | 1.25B | 1.36B | 1.01B | 2.05B | 2.63B | 2.77B | 3.24B | 4.79B | 2.54B | 931.40M | 1.95B | 2.39B | 4.45B | 6.06B | 11.40B | 8.84B | 4.71B | 5.47B | 7.38B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 615.05M | 1.25B | 1.36B | 1.01B | 2.05B | 2.63B | 2.77B | 3.24B | 4.79B | 2.54B | 931.40M | 1.95B | 2.39B | 4.45B | 6.06B | 11.40B | 8.84B | 4.71B | 5.47B | 7.38B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 1.09B | 1.83B | 1.72B | 2.45B | 2.99B | 3.63B | 4.90B | 5.90B | 7.63B | 5.11B | 3.23B | 3.96B | 4.36B | 6.88B | 9.17B | 15.18B | 12.83B | 9.93B | 11.55B | 17.24B |
| EBIT | 836.03M | 1.53B | 1.40B | 2.05B | 2.52B | 3.08B | 4.22B | 5.03B | 6.60B | 3.31B | 1.59B | 2.23B | 2.59B | 5.06B | 7.07B | 13.09B | 10.50B | 7.31B | 7.98B | 13.26B |
| Total operating expenses | -6.72B | -7.77B | -9.44B | -10.75B | -13.07B | -15.75B | -19.07B | -22.71B | -25.69B | -27.85B | -26.77B | -28.82B | -29.59B | -31.96B | -38.65B | -40.65B | -47.13B | -54.65B | -68.15B | -75.23B |
| Prepaid expenses | 0 | 0 | 985.40M | 1.09B | 188.90M | 65.00M | 59.40M | 85.00M | 96.70M | 102.60M | 146.60M | 142.50M | 167.70M | 152.80M | 146.20M | 187.40M | 188.60M | 311.90M | 482.90M | 573.10M |
| Deferred income, current | — | — | — | — | — | — | — | — | 107.40M | 220.30M | 215.30M | 98.50M | 77.70M | 503.00M | 1.18B | 208.50M | 267.70M | 274.00M | 168.70M | 154.70M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 130.20M | 115.00M | 170.80M | 170.80M | 399.30M | 509.00M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 489.50M | 530.70M | 590.10M | 681.60M | 828.40M | 859.20M | 979.50M | 1.36B | 1.54B | 1.84B | 2.12B | 2.28B | 2.32B | 1.48B | 2.27B | 2.22B | 2.66B | 2.08B | 4.29B | 4.21B |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.00M | 5.90M | 4.30M | 2.80M | 1.20M | 0 |
| Minority interest | 0 | 0 | 0 | -3.80M | -5.80M | -6.60M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 155.40M | 136.30M | 145.30M | 769.20M | 733.00M | 13.95B | 14.40B |
| Change in accrued expenses | 0 | — | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -157.27M | -185.40M | -219.40M | -336.20M | -378.70M | -438.60M | -466.60M | -467.80M | -661.20M | -368.50M | -153.40M | -2.40M | -153.20M | -154.10M | -1.22B | -1.02B | -1.01B | -1.01B | -507.40M | -1.01B |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800